Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Lassen

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patientsU Lassen, K Osterlind, M Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomographyU Lassen, P Andersen, G Daugaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: 'ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe', by A. Bayle et alJ García-Foncillas, D Arnold, B Avouac, et al.
British Journal of Cancer|February 16, 2012
A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumoursU Lassen, D L Nielsen, M Sørensen, et al.
Acta Neurologica Scandinavica|May 6, 2006
A prospective PET study of patients with glioblastoma multiformeP B Andersen, M Blinkenberg, U Lassen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow upU Lassen, P E Kristjansen, K Osterlind, et al.
Clinical Biochemistry|February 18, 2014
Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patientsM Grunnet, I J Christensen, U Lassen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2006
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysisB M Fischer, J Mortensen, S W Langer, et al.
ESMO Open|June 4, 2024
Comprehensive analysis of failure to carry out successful genomic profiling in a phase I settingL Belcaid, C Iden, I Jacobsen, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2004
The role of nuclear medicine in the diagnosis of cancer of unknown originH Demir, F Berk, M Raderer, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1995
Long-term survival in small-cell lung cancer: posttreatment characteristics in patients surviving 5 to 18+ years--an analysis of 1,714 consecutive patientsU Lassen, K Osterlind, M Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 26, 1998
Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomographyU Lassen, P Andersen, G Daugaard, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2024
Overcoming barriers in biomarker testing. Letter to the Editor regarding: 'ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe', by A. Bayle et alJ García-Foncillas, D Arnold, B Avouac, et al.
British Journal of Cancer|February 16, 2012
A phase I, dose-escalation study of TB-403, a monoclonal antibody directed against PlGF, in patients with advanced solid tumoursU Lassen, D L Nielsen, M Sørensen, et al.
Acta Neurologica Scandinavica|May 6, 2006
A prospective PET study of patients with glioblastoma multiformeP B Andersen, M Blinkenberg, U Lassen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 1, 1996
Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow upU Lassen, P E Kristjansen, K Osterlind, et al.
Clinical Biochemistry|February 18, 2014
Prognostic significance of circulating intact and cleaved forms of urokinase plasminogen activator receptor in inoperable chemotherapy treated cholangiocarcinoma patientsM Grunnet, I J Christensen, U Lassen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 25, 2006
A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysisB M Fischer, J Mortensen, S W Langer, et al.
ESMO Open|June 4, 2024
Comprehensive analysis of failure to carry out successful genomic profiling in a phase I settingL Belcaid, C Iden, I Jacobsen, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 10, 2004
The role of nuclear medicine in the diagnosis of cancer of unknown originH Demir, F Berk, M Raderer, et al.
Pageof 3